Clinical Rheumatology

Journal of the International League of Associations for Rheumatology

Publishing model:: Hybrid

Submit your manuscript

Clinical Rheumatology - Editor highlights - November 2021

Carlos Pineda Headshot Small Prof. Carlos Pineda provides his Editor-in-Chief highlights from this issue; where the article is not already Open Access, the read-only version of each article has been made available.

The issue can be found in full on SpringerLink.

Biologic disease-modifying anti-rheumatic drugs and kinase inhibitors: differences in efficacy and safety in rheumatoid arthritis Fleischmann, R.

Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study Lorenzin, M, Ortolan, A, Cozzi, G et al.

Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis Misra, DP, Rathore, U, Patro, P et al.